456 related articles for article (PubMed ID: 19201489)
1. Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders.
Conn PJ; Jones CK; Lindsley CW
Trends Pharmacol Sci; 2009 Mar; 30(3):148-55. PubMed ID: 19201489
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic acetylcholine receptors as CNS drug targets.
Langmead CJ; Watson J; Reavill C
Pharmacol Ther; 2008 Feb; 117(2):232-43. PubMed ID: 18082893
[TBL] [Abstract][Full Text] [Related]
3. Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders.
Moran SP; Maksymetz J; Conn PJ
Trends Pharmacol Sci; 2019 Dec; 40(12):1006-1020. PubMed ID: 31711626
[TBL] [Abstract][Full Text] [Related]
4. Positive allosteric modulation of M
Yohn SE; Conn PJ
Neuropharmacology; 2018 Jul; 136(Pt C):438-448. PubMed ID: 28893562
[TBL] [Abstract][Full Text] [Related]
5. Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.
Digby GJ; Shirey JK; Conn PJ
Mol Biosyst; 2010 Aug; 6(8):1345-54. PubMed ID: 20582339
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.
Jones CK; Byun N; Bubser M
Neuropsychopharmacology; 2012 Jan; 37(1):16-42. PubMed ID: 21956443
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic.
Yohn SE; Weiden PJ; Felder CC; Stahl SM
Trends Pharmacol Sci; 2022 Dec; 43(12):1098-1112. PubMed ID: 36273943
[TBL] [Abstract][Full Text] [Related]
8. Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders.
Teal LB; Gould RW; Felts AS; Jones CK
Adv Pharmacol; 2019; 86():153-196. PubMed ID: 31378251
[TBL] [Abstract][Full Text] [Related]
9. Novel M(1) allosteric ligands: a patent review.
Kuduk SD; Beshore DC
Expert Opin Ther Pat; 2012 Dec; 22(12):1385-98. PubMed ID: 23092292
[TBL] [Abstract][Full Text] [Related]
10. M1 muscarinic acetylcholine receptors: A therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer's disease?
Scarpa M; Hesse S; Bradley SJ
Adv Pharmacol; 2020; 88():277-310. PubMed ID: 32416870
[TBL] [Abstract][Full Text] [Related]
11. The Muscarinic Acetylcholine Receptor M
Bender AM; Garrison AT; Lindsley CW
ACS Chem Neurosci; 2019 Mar; 10(3):1025-1034. PubMed ID: 30280567
[TBL] [Abstract][Full Text] [Related]
12. M
Fu L; Luo Y; Niu L; Lin Y; Chen X; Zhang J; Tang W; Chen Y; Jiao Y
Bioorg Med Chem; 2024 May; 105():117728. PubMed ID: 38640587
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic receptor pharmacology and circuitry for the modulation of cognition.
Bubser M; Byun N; Wood MR; Jones CK
Handb Exp Pharmacol; 2012; (208):121-66. PubMed ID: 22222698
[TBL] [Abstract][Full Text] [Related]
14. Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy.
Wakeham MCL; Davie BJ; Chalmers DK; Christopoulos A; Capuano B; Valant C; Scammells PJ
ACS Chem Neurosci; 2022 Jan; 13(1):97-111. PubMed ID: 34905693
[TBL] [Abstract][Full Text] [Related]
15. Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4).
Smith E; Chase P; Niswender CM; Utley TJ; Sheffler DJ; Noetzel MJ; Lamsal A; Wood MR; Conn PJ; Lindsley CW; Madoux F; Acosta M; Scampavia L; Spicer T; Hodder P
J Biomol Screen; 2015 Aug; 20(7):858-68. PubMed ID: 25877150
[TBL] [Abstract][Full Text] [Related]
16. Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia.
Foster DJ; Choi DL; Conn PJ; Rook JM
Neuropsychiatr Dis Treat; 2014; 10():183-91. PubMed ID: 24511233
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development.
Wess J; Eglen RM; Gautam D
Nat Rev Drug Discov; 2007 Sep; 6(9):721-33. PubMed ID: 17762886
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic opportunities for muscarinic receptors in the central nervous system.
Felder CC; Bymaster FP; Ward J; DeLapp N
J Med Chem; 2000 Nov; 43(23):4333-53. PubMed ID: 11087557
[No Abstract] [Full Text] [Related]
19. Bitopic Binding Mode of an M
Bradley SJ; Molloy C; Bundgaard C; Mogg AJ; Thompson KJ; Dwomoh L; Sanger HE; Crabtree MD; Brooke SM; Sexton PM; Felder CC; Christopoulos A; Broad LM; Tobin AB; Langmead CJ
Mol Pharmacol; 2018 Jun; 93(6):645-656. PubMed ID: 29695609
[TBL] [Abstract][Full Text] [Related]
20. Discovery and Development of Muscarinic Acetylcholine M
Takai K; Enomoto T
Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
